| 1 | [SID26664947] | Active | Potency | 1.5849 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID26664947] | Active | IC50 | 2.1 | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay [AID624317, Type: confirmatory] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | IC50 | 2.1 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay | | AID | 624317 | | BioAssay type | confirmatory | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 3 | [SID103769282] | Active | EC50 | 4.4 | Antitrypanosomal activity against Trypanosoma brucei after 3 days by alamar blue assay [AID491644, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103769282 | | CID | 54677920 | | Outcome | Active | | EC50 | 4.4 [uM] | | BioAssay | Antitrypanosomal activity against Trypanosoma brucei after 3 days by alamar blue assay | | AID | 491644 | | BioAssay type | Literature | | Target | | | PubMed | 20527952 | | Data Table |  |
|
| 4 | [SID103769282] | Active | IC50 | 5 | Inhibition of hexahistidine-tagged Trypanosoma brucei UDP-galactose-4'epimerase expressed in Escherichia coli [AID491643, Type: Literature] | UDP-galactose 4-epimerase [gi:74934442] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103769282 | | CID | 54677920 | | Outcome | Active | | IC50 | 5 [uM] | | BioAssay | Inhibition of hexahistidine-tagged Trypanosoma brucei UDP-galactose-4'epimerase expressed in Escherichia coli | | AID | 491643 | | BioAssay type | Literature | | Target | UDP-galactose 4-epimerase [gi:74934442] | | PubMed | 20527952 | | Data Table |  |
|
| 5 | [SID26664947] | Active | Potency | 5.8584 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | Potency | 5.8584 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID26664947] | Active | IC50 | 7.01 | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay - Set 2 [AID651709, Type: confirmatory] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | IC50 | 7.01 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay - Set 2 | | AID | 651709 | | BioAssay type | confirmatory | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 7 | [SID26664947] | Active | IC50 | 11.76 | A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium [AID1863, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | IC50 | 11.76 [uM] | | BioAssay | A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium | | AID | 1863 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID26664947] | Active | IC50 | 13 | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. [AID1986, Type: confirmatory] | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | IC50 | 13 [uM] | | BioAssay | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. | | AID | 1986 | | BioAssay type | confirmatory | | Target | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] | | PubMed | | | Data Table |  |
|
| 9 | [SID26664947] | Active | IC50 | 16.46 | A Counter Screen to identiry small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium [AID2401, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | IC50 | 16.46 [uM] | | BioAssay | A Counter Screen to identiry small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium | | AID | 2401 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID26664947] | Active | IC50 | 19.34 | A screen for inhibitors of the PhoP regulon in Salmonella Typhimurium using a modified counterscreen. [AID1981, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | IC50 | 19.34 [uM] | | BioAssay | A screen for inhibitors of the PhoP regulon in Salmonella Typhimurium using a modified counterscreen. | | AID | 1981 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID26664947] | Active | IC50 | 38.35 | A Cell Based Assay for the Identification of Lead Compounds with Inhibitory Activity against HIV-1 Fusion (CCR5 Tropic HIV-1 Fusion Inhibition Assay) - Dose Response [AID2279, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | IC50 | 38.35 [uM] | | BioAssay | A Cell Based Assay for the Identification of Lead Compounds with Inhibitory Activity against HIV-1 Fusion (CCR5 Tropic HIV-1 Fusion Inhibition Assay) - Dose Response | | AID | 2279 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID26664947] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 13 | [SID26664947] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 14 | [SID26664947] | Active | EC50 | 50 | A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhimurium identified in the primary screen [AID2253, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | EC50 | 50 [uM] | | BioAssay | A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhimurium identified in the primary screen | | AID | 2253 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID26664947] | Active | Potency | 50.1187 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 16 | [SID26664947] | Active | | | Fluorescence-based biochemical high throughput confirmation assay to identify inhibitors of Protein Phosphatase 1 (PP1) [AID2358, Type: screening] | PPP1CA gene product [Homo sapiens] [gi:56790945] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay to identify inhibitors of Protein Phosphatase 1 (PP1) | | AID | 2358 | | BioAssay type | screening | | Target | PPP1CA gene product [Homo sapiens] [gi:56790945] | | PubMed | | | Data Table |  |
|
| 17 | [SID26664947] | Active | | | Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1). [AID2235, Type: screening] | PPP1CA gene product [Homo sapiens] [gi:56790945] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1). | | AID | 2235 | | BioAssay type | screening | | Target | PPP1CA gene product [Homo sapiens] [gi:56790945] | | PubMed | | | Data Table |  |
|
| 18 | [SID26664947] | Active | | | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC [AID463187, Type: screening] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC | | AID | 463187 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID26664947] | Active | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line [AID463079, Type: screening] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line | | AID | 463079 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID26664947] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats [AID651821, Type: screening] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats | | AID | 651821 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID26664947] | Active | | | Fluorescence-based biochemical high throughput confirmation assay to identify molecules that bind r(CAG) RNA repeats [AID652065, Type: screening] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay to identify molecules that bind r(CAG) RNA repeats | | AID | 652065 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID26664947] | Active | | | Counterscreen for molecules that bind rCAG RNA repeats: fluorescent based biochemical counterscreen assay for inhibitors of the DNA-based (5'CAG/3'GTC) TO-PRO-1 dye complex [AID652068, Type: screening] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | Counterscreen for molecules that bind rCAG RNA repeats: fluorescent based biochemical counterscreen assay for inhibitors of the DNA-based (5'CAG/3'GTC) TO-PRO-1 dye complex | | AID | 652068 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID26664947] | Active | | | uHTS identification of inhibitors of NadD in a Colorimetric assay [AID602399, Type: screening] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | uHTS identification of inhibitors of NadD in a Colorimetric assay | | AID | 602399 | | BioAssay type | screening | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 24 | [SID26664947] | Active | | | Single concentration confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay [AID624309, Type: screening] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay | | AID | 624309 | | BioAssay type | screening | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 25 | [SID26664947] | Active | | | uHTS identification of MazEF TA System activators via a fluorescence-based single-stranded RNase assay [AID504720, Type: screening] | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | uHTS identification of MazEF TA System activators via a fluorescence-based single-stranded RNase assay | | AID | 504720 | | BioAssay type | screening | | Target | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] | | PubMed | | | Data Table |  |
|
| 26 | [SID26664947] | Active | | | Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A) [AID588511, Type: screening] | Ano1 gene product [Mus musculus] [gi:334278898] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A) | | AID | 588511 | | BioAssay type | screening | | Target | Ano1 gene product [Mus musculus] [gi:334278898] | | PubMed | | | Data Table |  |
|
| 27 | [SID26664947] | Active | | | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening] | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate | | AID | 651958 | | BioAssay type | screening | | Target | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] | | PubMed | | | Data Table |  |
|
| 28 | [SID26664947] | Active | | | Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity [AID588549, Type: screening] | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588549 | | BioAssay type | screening | | Target | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] | | PubMed | | | Data Table |  |
|
| 29 | [SID26664947] | Active | | | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro) [AID1706, Type: screening] | 3C-like protease [Infectious bronchitis virus] [gi:73745819] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro) | | AID | 1706 | | BioAssay type | screening | | Target | 3C-like protease [Infectious bronchitis virus] [gi:73745819] | | PubMed | | | Data Table |  |
|
| 30 | [SID26664947] | Active | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 31 | [SID26664947] | Active | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 32 | [SID26664947] | Active | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 33 | [SID26664947] | Active | | | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) [AID602440, Type: screening] | SENP8 gene product [Homo sapiens] [gi:262118306] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Active | | BioAssay | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) | | AID | 602440 | | BioAssay type | screening | | Target | SENP8 gene product [Homo sapiens] [gi:262118306] | | PubMed | | | Data Table |  |
|
| 34 | [SID103769282] | Unspecified | EC50 | 50 | Cytotoxicity against human MRC5 cells after 3 days by alamar blue assay [AID491645, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103769282 | | CID | 54677920 | | Outcome | Unspecified | | EC50 | 50 [uM] | | BioAssay | Cytotoxicity against human MRC5 cells after 3 days by alamar blue assay | | AID | 491645 | | BioAssay type | Literature | | Target | | | PubMed | 20527952 | | Data Table |  |
|
| 35 | [SID26664947] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 36 | [SID26664947] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 37 | [SID26664947] | Inactive | Potency | 19.9526 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID26664947] | Inactive | | | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602247, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602247 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID26664947] | Inactive | | | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602248, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602248 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID26664947] | Inactive | | | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line [AID602250, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line | | AID | 602250 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID26664947] | Inactive | | | uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells [AID602274, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | BioAssay | uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells | | AID | 602274 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID26664947] | Inactive | | | HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity [AID602340, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | BioAssay | HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity | | AID | 602340 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID26664947] | Inactive | | | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity [AID602342, Type: screening] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | BioAssay | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602342 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID26664947] | Inactive | | | Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity [AID602363, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | BioAssay | Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity | | AID | 602363 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID26664947] | Inactive | | | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay [AID602449, Type: screening] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay | | AID | 602449 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID26664947] | Inactive | | | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity [AID623901, Type: screening] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | BioAssay | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity | | AID | 623901 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID26664947] | Inactive | | | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set [AID624256, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | BioAssay | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set | | AID | 624256 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID26664947] | Inactive | | | Small Molecules that selectively kill Giardia lamblia: qHTS [AID540267, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | BioAssay | Small Molecules that selectively kill Giardia lamblia: qHTS | | AID | 540267 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID26664947] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID26664947] | Inactive | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity [AID588334, Type: screening] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26664947 | | CID | 54677920 | | Outcome | Inactive | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity | | AID | 588334 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|